Human medicines European public assessment report (EPAR): Jelrix, autologous cartilage-derived articular chondrocytes, in-vitro expanded, Status: Application withdrawn

Human medicines European public assessment report (EPAR): Jelrix, autologous cartilage-derived articular chondrocytes, in-vitro expanded, Status: Application withdrawn

Human medicines European public assessment report (EPAR): Prevymis, letermovir, Date of authorisation: 08/01/2018, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Prevymis, letermovir, Date of authorisation: 08/01/2018, Revision: 18, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.